Sanofi gets CDSCO Panel nod to study Antidiabetic Drug Insulin Glargine and Lixisenatide Injection Dr. Divya Colin1 March 2024 6:00 PM ISTNew Delhi: The drug major Sanofi has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Low dietary cholesterol intake vital to prevent diabetes, especially for people at higher CV risk Aditi20 Jan 2023 8:00 PM ISTChina: According to a study published in Nutrition, Metabolism and Cardiovascular Diseases, the researchers have concluded that a positive...
Insulin Glargine Induces Less Insulin Antibody Than Other Insulin Regimens MD Bureau11 March 2022 10:00 AM ISTInsulin antibodies (IAs), which were found commonly developed in patients treated with exogenous insulin, might affect glycemic control due to their...
